Skip to main content

Table 1 Composition of the experimental M. hyopneumoniae bacterins and their route of administration

From: Efficacy of three innovative bacterin vaccines against experimental infection with Mycoplasma hyopneumoniae

Vaccine formulationDose (mL)Delivery systemImmune-stimulators (µg/dose)Antigen dose (CCU/dose)Administration route (primo and booster)
Lipo_DDA:TDB2DDA liposomesTDB (500)109IM
PLGA_TLRPLGA micro-particles (combined to ethylaminoethyl-dextran)Pam3Cys-SK4/CpG ODN SL03/resiquimod (80/80/80)
SWE_TLRSqualene-in-water emulsion
  1. CCU: colour changing units, IM: intramuscular, PLGA: poly(lactic-co-glycolic acid), DDA: dimethyl dioctadecylammonium, TDB: trehalose 6,6′-dibehenate.